Table 2.
Clinical characteristics for 45 SCN patients with wile type ELANE allele
| Pre-G-CSF Treatment | Post- G-CSF ANC | Post- G-CSF AMC | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Patient | Gender | AML/MDS | WBC ×109/l | RBC ×1012/l | MCV fl | Platelets ×109/l | ANC ×109/l | AMC ×109/l | ALC ×109/l | ||
| 1 | M | 5.4 | 5.2 | NA | 389 | 0.36 | 0.77 | 4.33 | NA | NA | |
| 2 | M | 3.3 | 4.6 | NA | 270 | 0.18 | 0.99 | 2.18 | 1.40 | 1.2 | |
| 5 | F | 4.9 | 4.3 | 76 | 404 | 0.28 | 0.65 | 3.50 | 1.22 | 0.50 | |
| 6 | M | 4.2 | 4.3 | 99 | 370 | 0.14 | 0.85 | 2.80 | 0.91 | 0.60 | |
| 7 | F | 3.1 | 3.9 | 82 | 247 | 0.09 | 0.30 | 2.55 | 2.09 | 0.48 | |
| 8 | F | 5.7 | NA | NA | 108 | 0.68 | 0.32 | 4.50 | NA | NA | |
| 9 | F | 4.3 | 4.6 | 100 | 188 | 0.04 | 1.28 | 3.24 | 3.51 | 0.59 | |
| 10 | M | 6.1 | 3.3 | 85 | 319 | 0.25 | 0.59 | 5.13 | NA | NA | |
| 11 | M | 3.3 | NA | NA | 949 | 0.12 | 0.17 | 2.84 | 1.24 | 0.31 | |
| 13 | F | AML | 6.1 | 4.4 | 74 | 201 | NA | NA | NA | NA | NA |
| 15 | M | NA | NA | NA | NA | NA | NA | NA | 0.24 | 1.65 | |
| 16 | M | 3.9 | 3.8 | 79 | 656 | 0.08 | 0.34 | 3.08 | 2.57 | 0.60 | |
| 17 | M | 4.1 | 4.5 | 76 | 376 | 0.12 | 1.86 | 1.79 | 1.12 | 1.74 | |
| 18 | M | 3.6 | 4.0 | NA | 336 | 0.43 | 0.50 | 0.00 | 2.02 | 0.19 | |
| 19 | F | 2.5 | 5.2 | NA | 240 | 0.28 | 0.31 | 1.75 | NA | NA | |
| 21 | F | 6.1 | 3.9 | 79 | 534 | 0.04 | 1.72 | 4.41 | 0.09 | 1.03 | |
| 22 | M | 11.9 | 3.5 | 85 | 532 | 0.57 | 4.69 | 6.19 | 2.42 | 10.71 | |
| 23 | F | 2.3 | 4.4 | 91 | 211 | 0.32 | 0.31 | 0.88 | 1.66 | 0.46 | |
| 24 | M | 6.4 | 3.7 | 86 | NA | 0.00 | 1.85 | 4.74 | 0.51 | 2.84 | |
| 25 | M | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| 26 | M | 2.8 | 3.7 | 90 | 243 | 0.23 | 0.26 | 2.41 | 0.33 | 0.45 | |
| 27 | F | 3.0 | 3.7 | 84 | 241 | 0.16 | 0.81 | 1.73 | 4.66 | 2.16 | |
| 28 | F | 2.6 | 2.9 | 111 | 263 | 0.41 | 0.31 | 1.69 | 0.06 | 0.45 | |
| 29 | F | 4.0 | 4.3 | 82 | 296 | 0.34 | 0.41 | 2.69 | NA | NA | |
| 30 | F | 4.3 | 4.8 | 81 | 379 | 0.22 | 0.85 | 3.11 | 0.54 | 0.75 | |
| 32 | M | 1.5 | 4.1 | 82 | 368 | 0.14 | 0.15 | 1.05 | 0.14 | 0.06 | |
| 33 | F | AML | 6.6 | 3.9 | 77 | 328 | 0.80 | 0.60 | 4.20 | 6.00 | 1.10 |
| 34 | M | AML | 1.9 | 4.7 | 89 | 148 | 0.22 | 0.04 | 1.46 | 1.98 | 0.08 |
| 37 | F | AML | 3.5 | 4.9 | 77 | 255 | 0.07 | 0.82 | 2.14 | 2.03 | 0.77 |
| 39 | M | AML | 6.4 | 4.8 | NA | 464 | 0.00 | 0.77 | 5.18 | 4.42 | 1.20 |
| 41 | M | MDS | 10.6 | 3.8 | 68 | 564 | 0.18 | 2.65 | 6.89 | 3.44 | 0.68 |
| 43 | M | 11.8 | 4.3 | 80 | 351 | 0.16 | 2.13 | 8.75 | 0.17 | 1.49 | |
| 44 | M | 6.9 | 4.7 | 72 | 390 | 0.15 | 1.40 | 4.46 | 0.07 | 1.15 | |
| 45 | M | 3.2 | 4.4 | 81 | 298 | 0.18 | 0.37 | 2.29 | 1.93 | 0.38 | |
| 46 | F | 4.1 | 5.0 | NA | 376 | 0.04 | 1.39 | 2.01 | 1.48 | 0.99 | |
| 64 | M | 7.9 | 4.3 | 73 | 349 | 0.28 | 1.48 | 5.97 | 4.28 | 1.10 | |
| 65 | M | 6.7 | 3.9 | 73 | 463 | 0.08 | 1.23 | 4.15 | 2.05 | 0.62 | |
| 66 | F | 3.0 | 4.5 | 76 | 238 | 0.59 | 0.47 | 2.15 | 1.05 | 0.38 | |
| 67 | M | 7.4 | 4.2 | 75 | 390 | 0.18 | 1.61 | 5.06 | 3.70 | 2.39 | |
| 68 | M | 4.1 | 4.0 | 76 | 230 | 0.11 | 0.45 | 3.16 | 11.78 | 0.43 | |
| 69 | M | 12.9 | 3.2 | 94 | 524 | 0.00 | 3.15 | 8.39 | 3.67 | 0.23 | |
| 70 | F | 7.2 | 4.2 | 78 | 389 | 0.09 | 1.74 | 5.24 | 0.37 | 0.42 | |
| 71 | M | 5.5 | 4.8 | 107 | 252 | 0.18 | 0.48 | 4.52 | 0.37 | 0.24 | |
| 72 | M | 5.1 | 4.4 | 74 | 417 | 0.09 | 1.08 | 3.38 | 5.77 | 1.73 | |
| 73 | M | 11.0 | 3.98 | 79 | 556 | 0.00 | 3.30 | 7.15 | 1.17 | 0.36 | |
ANC: absolute neutrophil count; AMC: absolute monocyte count; ALC: absolute lymphocyte count